These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1434835)

  • 21. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission.
    De Witte T; Awwad B; Boezeman J; Schattenberg A; Muus P; Raemaekers J; Preijers F; Strijckmans P; Haanen C
    Bone Marrow Transplant; 1994 Nov; 14(5):767-74. PubMed ID: 7889010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
    Mrsić M; Nemet D; Labar B; Bogdanić V; Radman I; Zupancić-Salek S; Kovacević-Metelko J; Aurer I; Maravić N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1268-70. PubMed ID: 8442109
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment with imatinib-combined chemotherapy for relapsed Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation.
    IMAHASHI N; TOKUNAGA M; NISHIWAKI S; YANAGISAWA M; OZAWA Y; MIYAMURA K
    Rinsho Ketsueki; 2009 Nov; 50(11):1612-5. PubMed ID: 20009435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia.
    Porcellini A; Manna A; Moretti L; Carotenuto M; Greco MM; Bodenizza C
    Bone Marrow Transplant; 1989 May; 4(3):331-3. PubMed ID: 2659120
    [No Abstract]   [Full Text] [Related]  

  • 25. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.
    Carella AM; Piatti G; Frassoni F; Maraone MP; Van Lint MT; Bacigalupo A
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469
    [No Abstract]   [Full Text] [Related]  

  • 28. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
    Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
    Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of childhood acute lymphoblastic leukemia in first remission with allogeneic bone marrow transplantation or with intensive chemotherapy: a cooperative Italian study. The AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo), Italy.
    Uderzo C; Valsecchi MG; Balduzzi A; Rovelli A; Dini G; Miniero R; Locatelli F; Rondelli R; Arcese W; Andolina M; Messina C; Polchi P; Biagi E; Arrigo C; Silvestri D; Masera G; Bacigalupo A
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():25-7. PubMed ID: 8932793
    [No Abstract]   [Full Text] [Related]  

  • 30. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T; Kojima S; Kato K
    Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous bone marrow transplantation for acute lymphoblastic leukemia.
    Sallan SE; Niemeyer CM; Billett AL; Lipton JM; Tarbell NJ; Gelber RD; Murray C; Pittinger TP; Wolfe LC; Bast RC
    J Clin Oncol; 1989 Nov; 7(11):1594-601. PubMed ID: 2809677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
    Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
    Carella AM
    Haematologica; 1992; 77(4):348-51. PubMed ID: 1358772
    [No Abstract]   [Full Text] [Related]  

  • 35. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Société Française de Greffe de Moelle.
    von Bueltzingsloewen A; Esperou-Bourdeau H; Souillet G; Demeocq F; Mechinaud-Lacroix F; Michel G; Sadoun A; Bernaudin F; Cornu G; Donadieu J
    Bone Marrow Transplant; 1995 Oct; 16(4):521-7. PubMed ID: 8528167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
    Harada M
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.
    van Besien K; Tabocoff J; Rodriguez M; Andersson B; Mehra R; Przepiorka D; Dimopoulos M; Giralt S; Suki S; Khouri I
    Bone Marrow Transplant; 1995 Apr; 15(4):549-55. PubMed ID: 7655380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autologous transplantation in acute lymphoblastic leukemia in adults].
    Piatkowska-Jakubas B; Wegrzyn J; Rucińska M; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():52-6. PubMed ID: 10494183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remission.
    Barrett AJ; Horowitz MM; McCarthy DM; Kanfer E; Bortin MM
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():247-9. PubMed ID: 2653514
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of chemotherapy and autologous and allogeneic transplantation as postinduction regimen in adult acute lymphoblastic leukemia: a preliminary multicentric study.
    Fiere D; Broustet A; Leblond V; Maraninchi D; Castaigne S; Flesch M; Varet B; Vernant JP; Milpied N; Troussard X
    Haematol Blood Transfus; 1990; 33():409-12. PubMed ID: 2182431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.